# Endoprosthesis Treatment Effects on Human Abdominal Aorta Aneurysms (AAA) Metabolic Activity

> **NCT01253252** · NA · COMPLETED · sponsor: **Central Hospital, Nancy, France** · enrollment: 45 (actual)

## Conditions studied

- Abdominal Aortic Aneurysm

## Interventions

- **RADIATION:** [18F] Fluorodeoxyglucose PET Scan Imaging
- **RADIATION:** CT scan
- **BIOLOGICAL:** Blood sampling for biological investigations

## Key facts

- **NCT ID:** NCT01253252
- **Lead sponsor:** Central Hospital, Nancy, France
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2009-08
- **Final completion:** —
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2017-07-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01253252

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01253252, "Endoprosthesis Treatment Effects on Human Abdominal Aorta Aneurysms (AAA) Metabolic Activity". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01253252. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*